Niche Innovator Deltex Medical On Market Access, EU MDR And A Mission To Change The World
TrueVue Oesophageal Doppler Monitor Developer Guards Its Space In A Market Characterized By Multinationals
The UK market has become tougher for smaller innovators, says Andy Mears, CEO of Deltex Medical, which plans to launch a new iteration of its minimally invasive ultrasound-based technology, the oesophageal Doppler monitor. He explained how market access challenges have steepened.
